• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牙科中血管收缩剂的禁忌证:第一部分。心血管疾病。

Contraindications to vasoconstrictors in dentistry: Part I. Cardiovascular diseases.

作者信息

Pérusse R, Goulet J P, Turcotte J Y

机构信息

Section of Oral Medicine, School of Dental Medicine, Universit'e Laval, Ste.-Foy, Quebec, Canada.

出版信息

Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):679-86. doi: 10.1016/0030-4220(92)90365-w.

DOI:10.1016/0030-4220(92)90365-w
PMID:1437073
Abstract

This article reviews the main contraindications of vasoconstrictors in cardiac patients, notably unstable angina, recent myocardial infarction, recent coronary artery bypass surgery, refractory arrhythmias, untreated or uncontrolled hypertension, and untreated or uncontrolled congestive heart failure. Extensive survey of the literature has been completed, giving specific guidelines for a rational use of vasoconstrictors in this category of medically compromised patients.

摘要

本文综述了血管收缩剂在心脏病患者中的主要禁忌证,尤其是不稳定型心绞痛、近期心肌梗死、近期冠状动脉搭桥手术、难治性心律失常、未治疗或未控制的高血压以及未治疗或未控制的充血性心力衰竭。已完成对文献的广泛调研,给出了在这类有医疗问题的患者中合理使用血管收缩剂的具体指导原则。

相似文献

1
Contraindications to vasoconstrictors in dentistry: Part I. Cardiovascular diseases.牙科中血管收缩剂的禁忌证:第一部分。心血管疾病。
Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):679-86. doi: 10.1016/0030-4220(92)90365-w.
2
Contraindications to vasoconstrictors in dentistry: Part III. Pharmacologic interactions.牙科中血管收缩剂的禁忌证:第三部分。药物相互作用。
Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):692-7. doi: 10.1016/0030-4220(92)90367-y.
3
Contraindications to vasoconstrictors in dentistry: Part II. Hyperthyroidism, diabetes, sulfite sensitivity, cortico-dependent asthma, and pheochromocytoma.牙科中血管收缩剂的禁忌证:第二部分。甲状腺功能亢进、糖尿病、亚硫酸盐敏感性、皮质激素依赖型哮喘和嗜铬细胞瘤。
Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):687-91. doi: 10.1016/0030-4220(92)90366-x.
4
[Local anesthetics and cardiopathic patients].[局部麻醉药与心脏病患者]
G Anest Stomatol. 1990 Oct-Dec;19(4):19-23.
5
Local anesthetics and vasoconstrictors in patients with compromised cardiovascular systems.
Gen Dent. 1993 Mar-Apr;41(2):161-4.
6
Contraindications to the use of catecholamine vasoconstrictors in dental local analgesics.
N Z Dent J. 1973 Jan;69(315):25-30.
7
[Emergencies evolving from local anesthesia].[局部麻醉引发的紧急情况]
Refuat Hapeh Vehashinayim (1993). 2002 Jan;19(1):13-8, 98.
8
Dental treatment in very high risk patients with active ischemic heart disease.患有活动性缺血性心脏病的极高风险患者的牙科治疗。
Oral Surg Oral Med Oral Pathol. 1993 Sep;76(3):298-300. doi: 10.1016/0030-4220(93)90257-5.
9
[Local anesthesia with and without vasoconstrictors: indications, contra-indications and complications in relation to the health of the patient].[使用和不使用血管收缩剂的局部麻醉:与患者健康相关的适应症、禁忌症及并发症]
Rev Belge Med Dent (1984). 1999;54(4):242-58.
10
[Cardiovascular emergencies in dental surgery].[牙科手术中的心血管急症]
G Anest Stomatol. 1990 Oct-Dec;19(4):11-7.

引用本文的文献

1
Dental Management Considerations for Patients with Cardiovascular Disease-A Narrative Review.心血管疾病患者的牙科管理考量——一篇叙述性综述
Rev Cardiovasc Med. 2022 Jul 20;23(8):261. doi: 10.31083/j.rcm2308261. eCollection 2022 Aug.
2
Effect of Cooling of Lidocaine with Epinephrine on the Anesthetic Success of Supplementary Intraligamentary Injection after a Failed Primary Inferior Alveolar Nerve Block: A Randomized Controlled Trial.利多卡因肾上腺素局部冷却对初次下牙槽神经阻滞失败后补充行内上牙槽骨间注射麻醉效果的影响:一项随机对照试验。
Eur Endod J. 2023 Aug;8(4):239-245. doi: 10.14744/eej.2023.41275.
3
Does the presence and amount of epinephrine in 2% lidocaine affect its anesthetic efficacy in the management of symptomatic maxillary molars with irreversible pulpitis?
2%利多卡因中肾上腺素的存在与否及含量是否会影响其在治疗有症状的上颌磨牙不可逆性牙髓炎时的麻醉效果?
J Dent Anesth Pain Med. 2022 Feb;22(1):39-47. doi: 10.17245/jdapm.2022.22.1.39. Epub 2022 Jan 24.
4
Anti-Inflammatory Fibronectin-AgNP for Regulation of Biological Performance and Endothelial Differentiation Ability of Mesenchymal Stem Cells.抗炎症纤维连接蛋白-AgNP 调控间充质干细胞的生物学性能和内皮分化能力。
Int J Mol Sci. 2021 Aug 26;22(17):9262. doi: 10.3390/ijms22179262.
5
Cardiovascular Comparison of 2 Types of Local Anesthesia With Vasoconstrictor in Older Adults: A Crossover Study.两种含血管收缩剂的局部麻醉对老年人心血管影响的比较:一项交叉研究。
Anesth Prog. 2019 Fall;66(3):133-140. doi: 10.2344/anpr-66-02-04.
6
Excisional Biopsy of the Pyogenic Granuloma in Very High-Risk Patient.极高危患者脓性肉芽肿的切除活检
Case Rep Dent. 2018 Oct 14;2018:5180385. doi: 10.1155/2018/5180385. eCollection 2018.
7
Marfan Syndrome: oral implication and management.马凡综合征:口腔表现及处理
Oral Implantol (Rome). 2017 Sep 27;10(2):87-96. doi: 10.11138/orl/2017.10.2.087. eCollection 2017 Apr-Jun.
8
Evaluation of the haemodynamic and metabolic effects of local anaesthetic agent in routine dental extractions.局部麻醉剂在常规拔牙术中的血流动力学和代谢效应评估。
J Maxillofac Oral Surg. 2013 Dec;12(4):424-8. doi: 10.1007/s12663-012-0449-4. Epub 2012 Dec 2.
9
The Incidence of Intravascular Needle Entrance during Inferior Alveolar Nerve Block Injection.下牙槽神经阻滞注射时血管内进针的发生率
J Dent Res Dent Clin Dent Prospects. 2008 Winter;2(1):38-41. doi: 10.5681/joddd.2008.008. Epub 2008 May 15.
10
Comparison of hemodynamic effects of lidocaine, prilocaine and mepivacaine solutions without vasoconstrictor in hypertensive patients.比较无血管收缩剂的利多卡因、丙胺卡因和甲哌卡因溶液在高血压患者中的血液动力学效应。
J Appl Oral Sci. 2010 Jul-Aug;18(4):354-9. doi: 10.1590/s1678-77572010000400006.